Respiratory disease monitoring using clinically validated biomarkers
Tell Me More

Resmonics presents:

Our first product, Asthma Guardian, turns a patient’s smartphone into a guardian angel at night. It protects patients from life-threatening asthma attacks and helps them to stay in control of their disease. The only thing patients need to do is to place their smartphones in their bedroom at night.

Asthma Guardian closes an important gap in today’s patient journey: a disease monitoring tool that is truly compatible with everyday life. This is how Asthma Guardian works:

Keep the smartphone in your bedroom

Asthma Guardian monitors symptoms at night.
Automatically and passively.

Enjoy your newly won peace of mind

In times of medical necessity, we will alert you.
No risk, no alerts.

Explore novel and unique disease insights

We enrich your subjective disease assessments.
With objective facts.


Strong claims require strong evidence. Our products are based on five years of deep learning and respiratory medicine research. Explore our growing evidence base by browsing through an excerpt of our peer-reviewed papers and posters.

24/7 Cough Monitoring in Hospitalized Covid-19 Patients

Swiss MedTech Day 2020

Nocturnal cough and sleep quality as markers for asthma

Forthcoming [New!]

Deep learning cough detection in real-world asthma


Characteristics of nocturnal cough in asthma

Forthcoming [New!]

Deep learning breathing pattern detection

UbiComp 2019

Device-agnostic cough detection with deep learning


Nocturnal cough and sleep quality as markers for asthma

BMJ Open

Systematic review of publicly available asthma apps

JMIR mhealth and uhealth

Enhancing asthma control through IT (mHealth)

WI Conference

Meet the team

Our core value is to develop innovative technology to improve patients' everyday lives. We operate at the intersection of respiratory medicine, artificial intelligence, and business innovation.

“My MSc in psychology and years of research experience in digital health made me realize that it is often more worthwhile to change technology than human behavior, in particular in chronic care.”

Dr. Peter Tinschert

Co-Founder, CEO

“My PhD and my computer science degree taught me how to build state-of-the-art tech. What excites me the most, however, is when technology actually improves patient lives in the real world.”

Dr. Iris Shih

Co-Founder, CTO

We are hiring!

Are you looking for a new challenge? Join us and help us on our mission to bring AI-based digital biomarkers "from bench to bedside"! We look forward to hearing from you.

Open positions:

Interested in Asthma Guardian? Contact Us!

We would love to get in contact with you!